Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20142522 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL4260574 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL627232 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791104 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791152 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL9398013 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791220 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL20746956 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL21126455 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL11262421 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015091871-A1 | PROCESS FOR MANUFACTURING AN EPOXIDE | SOLVAY SA (BE) | 2015-06-25 | — | — | WO | claimed |
| EP-1904898-B1 | METHOD FOR FINE LINE RESIST STRIPPING | ATOTECH DEUTSCHLAND GMBH (DE) | 2011-08-17 | — | — | EP | claimed |
| CN-101185034-A | Method for fine line resist stripping | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-05-21 | — | — | CN | claimed |
| EP-1904898-A1 | METHOD FOR FINE LINE RESIST STRIPPING | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-04-02 | — | — | EP | claimed |
| WO-2006128642-A1 | METHOD FOR FINE LINE RESIST STRIPPING | ATOTECH DEUTSCHLAND GMBH (DE) | 2006-12-07 | — | — | WO | claimed |
| EP-1729179-A1 | Method for fine line resist stripping | ATOTECH DEUTSCHLAND GMBH (DE) | 2006-12-06 | — | — | EP | claimed |
| US-4272502-A | Process for preparing gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1981-06-09 | — | — | US | claimed |
| US-4254092-A | Method for separating hydrogen chloride and hydrogen bromide | CHEMISCHE WERKE HULS AG (DE) | 1981-03-03 | — | — | US | claimed |
| US-3970680-A | Storage-stable diisocyanate compositions | IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) | 1976-07-20 | — | — | US | claimed |
| US-20240216515-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-07-04 | — | — | US | disclosed |
| US-20240216515-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-07-04 | — | — | US | disclosed |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | RECODE THERAPEUTICS, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | RECODE THERAPEUTICS, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240207178-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-06-27 | — | — | US | disclosed |
| EP-0008611-A1 | Process for the recovery of gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HÜLS AG (DE) | 1980-03-19 | — | — | EP | disclosed |
| EP-0008330-A1 | Process for the separation of hydrogen chloride and hydrogen bromine | CHEMISCHE WERKE HÜLS AG (DE) | 1980-03-05 | — | — | EP | disclosed |
| EP-0003472-A2 | Process for separating hydrogen chloride from solutions of amino-hydrochlorides | CHEMISCHE WERKE HÜLS AG (DE) | 1979-08-22 | — | — | EP | disclosed |
| US-4115530-A | EXTRACTION WITH AMINES | CHEMISCHE WERKE HULS AG (DE) | 1978-09-19 | — | — | US | disclosed |
| US-4024189-A | MULTI-STEP, ALKYL AMINES | ETHYL CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-3970680-A | Storage-stable diisocyanate compositions | IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207178-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | CHMP4B, LIPA, NPC1L1 | DNM1 307/4885THRB 2609/4885TSHR 2262/4885 |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | LIPA, NPC1L1, NPC1 | DNM1 487/4885THRB 4690/4885TSHR 3323/4885 |
| US-20240216515-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | PNLIP, LIPA, PHOSPHO1 | DNM1 1488/4885THRB 1435/4885TSHR 2016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.